Coping with COVID-19: Recent Episodes
Modern Aesthetics
This new series tackles the issues that are top of mind for dermatologists, plastic surgeons, and other aesthetic specialists as the country deals with the escalating COVID-19 crisis. Semi-weekly episodes will feature both physicians and experts in various fields discussing issues like staff management, getting up to speed on telemedicine, supporting front line colleagues, and more.
Clinical pharmacy specialist Adam Jackson, PharmaD offers his expertise and opinion on the Covid-19 pandemic in 2022. He and a panel of leading aesthetic physicians discuss current statistics, vaccines, safety protocols, and risk mitigation strategies that may be here to stay.
Aesthetic physicians share the steps they've taken to protect their staff, patients, and practice amid rising Covid-19 cases in early 2022. They discuss which safety protocols are working and more with clinical pharmacy specialist Adam Jackson, PharmaD.
The Omicron variant caused a surge in COVID-19 cases throughout the US in December 2021 and January 2022. Many hospitals, faced also with staffing shortages, were overcroweded, and some health systems even postponed elective surgeries. Infectious diseases clinical pharmacy specialist Adam Jackson, PharmD joins the panel of aesthetic physicians to discuss the new variant and its impact on the pandemic.
After more than a year of virtual conferences and Zoom meetings, many medical meetings are shifing back to in-person events. Leading aesthetic physicians discuss upcoming meetings, precautions that are and should be in place, and the pros and cons of mask and vaccine mandates for these events. Plus, they share their thoughts on the future of these events.
Aesthetic experts report on adverse events they are seeing in patients who have received dermal fillers that may be connected to the COVID-19 vaccine. The physicians discuss cases and how what they're doing in their practices to counter these complications.
As COVID-19 cases continue to rise as the Delta variant spreads throughout the country, aesthetic physicians discuss the impact on their practices. The panelists share adjustments they’re making to safety protocols for practices, including what they’re requiring of staff and patients in terms of masking and vaccines.
Can you mandate that your staff get vaccinated? What if an employee refuses? Are there exemptions you should be aware of? The panel speaks to special guest David J. Goldberg, MD, JD about your rights and your employees’ rights. Hear how these aesthetic physicians are navigating this new issue in their practices.
Even following best practices, there is a risk for COVID-19 exposure in practices. So how can aesthetic physicians minimize risk? And how does vaccination change protocols? Panelists discuss in a special session with guest Adam Jackson, PharmD.
From "garbage data" to "nothing new," aesthetic experts weigh in on reports of reactions to the COVID-19 vaccine among patients who have received dermal fillers. They identify science-based strategies for treatment and patient education. Infectious diseases clinical pharmacy specialist Adam Jackson, PharmD joins the panel to discuss the data and vaccine science.
Our expert panel of dermatologists and aesthetic physicians convene to discuss the challenges and successes they’ve had since re-opening their practices after shutdowns due to COVID-19. From new check-in protocols to scaled back schedules and mask education for patients, these physicians from around the country share changes they’ve made in their practices to ensure safety and a positive patient experience. Featuring: Joel L. Cohen, MD; Doris Day, MD; Steve Dayan, MD; Michael Gold, MD; Joel Schlessinger, MD; and Amy Taub, MD
Dermatologists and aesthetic physicians discuss what their practices look like as they re-open or plan to re-open. They share tips for keeping themselves, their staff, and their patients safe, which procedures they're likely to perform, and how the patient experience may change in a post-COVID-19 world.
How quickly will the aesthetic and dermatology markets bounce back? What will be the long-term implications of COVID-19 on patient volume, revenue, staffing, and more for practices? Experts look ahead and make predictions for what the future could look like. Featuring: Joel L. Cohen, MD; Doris Day, MD; Steve Dayan, MD; Michael Gold, MD; Mark S. Nestor, MD, PhD; Joel Schlessinger, MD; and Amy Taub, MD
Self-care is important in an era of isolation and uncertainty. Panelists discuss a role for dietary supplements, nutrition, and sleep. Discover how much sleep individuals need and how stress and alcohol affect sleep rhythms.
Even as some aesthetic practices start to reopen, practices aren't likely to look the same. In part 3, aesthetic physicians discuss why high-volume, high-touch practices won't be possible in the near future, as well as other challenges that practices will face.
How will aesthetic meetings and aesthetic medical education look post COVID-19? How will industry relationships change? In part 2, aesthetic physicians offer insights on the role of virtual meetings, when in-person meetings could start again, and how they will work with industry.
As some states start to allow the reopening of some businesses, dermatologists and aesthetic physicians discuss the processes they will need to put in place to keep themselves, their patients, and their staff healthy. From masks to consent forms to limiting who can enter the practice, experts share their thoughts on reopening.
The COVID-19 pandemic has forced practice closures and a halt to aesthetic procedures, but virtual consults and educational webinars can keep dermatologists and aesthetic physicians connected to their patients. Sabrina Fabi, MD and Dhaval Bhanusali, MD share insights into what's working for them and the benefits they're seeing.
Wendy Lewis, Anthony Youn, MD, and Jason Bloom, MD, discuss when and how aesthetic practices will reopen and what “normal” may look like in a post COVID-19 world including a growing role for virtual consults and peer-to-peer training.
What’s the future for clinical trials? Experts discuss how they’re preparing now for when they can reopen and restart clinical trials in the future. They share ideas for what new protocols and changes will be in place.
Some clinical trials are making due with virtual patient interactions while others are at least temporarily on hold. Experts discuss how trials are adapting and discuss the potential impact on future developments. Featuring: Macrene Alexiades, MD, PhD; Jeffrey S. Dover, MD; Roy G. Geronemus, MD; David H. McDaniel, MD; and E. Victor Ross, MD.
In an era of isolation, people crave connections. Learn how to use social media to educate, make connections, and reinforce patient relationships. Experts discuss the need for sensitivity and strategies for marketing when emerging from practice shut downs. Featuring Wendy Lewis, Anthony Youn, MD, and Jason Bloom, MD.
For many practices, transitioning to telemedicine has presented challenges. A panel of dermatologists shares tips for how to make the most of the teleconsult. From patient education tools to scheduling to privacy and coding, they discuss what's worked for them.
How will aesthetics practices reopen as the COVID-19 crisis abates, and what will be the long-term effects of the pandemic on the industry? A panel of experts discuss what we know from historical precedent and medical science and assess what we still need to learn.
Dermatology and aesthetic practices around the country have been forced to shut down, leaving many physicians with questions about what their insurance does and doesn’t cover during the COVID-19 pandemic. In this episode, Jason O’Dell, a financial consultant and insurance specialist, discusses frequently asked insurance questions with Jeanine Downie, MD and Steve Dayan, MD. They also share tips for assessing current coverage and determining what changes you may want to make for the future.
From negotiating with vendors to applying for loans to borrowing from personal savings, there are many places practices may be looking for money as they confront closures due to the COVID-19 pandemic. In this episode, Carole Foos, CPA and David Mandell, JD, MBA discuss options and assess issues like tax implications and long-term losses with Joel Schlessinger, MD.
Peter Pitts, Former Associate Commissioner at FDA and co-founder of Center for Medicine in the Public Interest, speaks with Dr. Neal Bhatia about access to drugs for fighting COVID-19 and the FDA's ability to fast-track treatments and vaccines in a time of crisis. Alison Ehrlich, MD discusses the use of hydroxychloroquine in dermatology and strategies to protect patient access.
Dermatologists and aesthetic physicians are adapting new technologies to practice. What are the short-term and long-term implications for these newer tools in practice? Experts offer tips for getting started with telemedicine and share their experiences with virtual patient care.
This episode tackles the role of dermatologists and aesthetic surgeons to support the response to COVID-19. Find out how physicians are donating supplies and expertise and how they are adapting their practices to confront the pandemic.